Genetics of human cardiovascular disease

Cell

Volumn 148, Issue 6, 2012, Pages 1242-1257

  Kathiresan, Sekar ^a,b,c   Srivastava, Deepak ^d,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MONOGENIC DISORDER; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84858383447     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.03.001     Document Type: Review

References (134)

1. M. Abifadel, M. Varret, J.P. Rabs, D. Allard, K. Ouguerram, M. Devillers, C. Cruaud, S. Benjannet, L. Wickham, and D. Erlich Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat. Genet. 34 2003 154 156
2. D. Altshuler, M.J. Daly, and E.S. Lander Genetic mapping in human disease Science 322 2008 881 888
3. M.J. Bamshad, S.B. Ng, A.W. Bigham, H.K. Tabor, M.J. Emond, D.A. Nickerson, and J. Shendure Exome sequencing as a tool for Mendelian disease gene discovery Nat. Rev. Genet. 12 2011 745 755
4. C.T. Basson, D.R. Bachinsky, R.C. Lin, T. Levi, J.A. Elkins, J. Soults, D. Grayzel, E. Kroumpouzou, T.A. Traill, and J. Leblanc-Straceski Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome Nat. Genet. 15 1997 30 35
5. K.E. Berge, H. Tian, G.A. Graf, L. Yu, N.V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H.H. Hobbs Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290 2000 1771 1775
6. G. Bonne, L. Carrier, J. Bercovici, C. Cruaud, P. Richard, B. Hainque, M. Gautel, S. Labeit, M. James, and J. Beckmann Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy Nat. Genet. 11 1995 438 440
7. L.M. Boyden, M. Choi, K.A. Choate, C.J. Nelson-Williams, A. Farhi, H.R. Toka, I.R. Tikhonova, R. Bjornson, S.M. Mane, and G. Colussi Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities Nature 482 2012 98 102
8. S.R. Braam, L. Tertoolen, A. van de Stolpe, T. Meyer, R. Passier, and C.L. Mummery Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes Stem Cell Res. (Amst.) 4 2010 107 116
9. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47
10. B.G. Bruneau, G. Nemer, J.P. Schmitt, F. Charron, L. Robitaille, S. Caron, D.A. Conner, M. Gessler, M. Nemer, C.E. Seidman, and J.G. Seidman A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease Cell 106 2001 709 721
11. R. Burkhardt, S.A. Toh, W.R. Lagor, A. Birkeland, M. Levin, X. Li, M. Robblee, V.D. Fedorov, M. Yamamoto, and T. Satoh Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice J. Clin. Invest. 120 2010 4410 4414
12. C4D (Coronary Artery Disease Genetic Consortium) A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease Nat. Genet. 43 2011 339 344
13. V. Cañadas, I. Vilacosta, I. Bruna, and V. Fuster Marfan syndrome. Part 1: pathophysiology and diagnosis Nat. Rev. Cardiol. 7 2010 256 265
14. L. Carrier, C. Hengstenberg, J.S. Beckmann, P. Guicheney, C. Dufour, J. Bercovici, E. Dausse, I. Berebbi-Bertrand, C. Wisnewsky, and D. Pulvenis Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11 Nat. Genet. 4 1993 311 313
15. X. Carvajal-Vergara, A. Sevilla, S.L. D'Souza, Y.S. Ang, C. Schaniel, D.F. Lee, L. Yang, A.D. Kaplan, E.D. Adler, and R. Rozov Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
16. S.S. Chang, S. Grunder, A. Hanukoglu, A. Rösler, P.M. Mathew, I. Hanukoglu, L. Schild, Y. Lu, R.A. Shimkets, and C. Nelson-Williams Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1 Nat. Genet. 12 1996 248 253
17. Q. Chen, G.E. Kirsch, D. Zhang, R. Brugada, J. Brugada, P. Brugada, D. Potenza, A. Moya, M. Borggrefe, and G. Breithardt Genetic basis and molecular mechanism for idiopathic ventricular fibrillation Nature 392 1998 293 296
18. M. Choi, U.I. Scholl, P. Yue, P. Björklund, B. Zhao, C. Nelson-Williams, W. Ji, Y. Cho, A. Patel, and C.J. Men K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension Science 331 2011 768 772
19. R. Clarke, J.F. Peden, J.C. Hopewell, T. Kyriakou, A. Goel, S.C. Heath, S. Parish, S. Barlera, M.G. Franzosi, S. Rust PROCARDIS Consortium Genetic variants associated with Lp(a) lipoprotein level and coronary disease N. Engl. J. Med. 361 2009 2518 2528
20. J.C. Cohen, R.S. Kiss, A. Pertsemlidis, Y.L. Marcel, R. McPherson, and H.H. Hobbs Multiple rare alleles contribute to low plasma levels of HDL cholesterol Science 305 2004 869 872
21. J.C. Cohen, E. Boerwinkle, T.H. Mosley Jr., and H.H. Hobbs Sequence variations in PCSK9, low LDL, and protection against coronary heart disease N. Engl. J. Med. 354 2006 1264 1272
22. M.E. Curran, I. Splawski, K.W. Timothy, G.M. Vincent, E.D. Green, and M.T. Keating A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell 80 1995 795 803
23. G. Davey Smith, and S. Ebrahim 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32 2003 1 22
24. H.C. Dietz New therapeutic approaches to mendelian disorders N. Engl. J. Med. 363 2010 852 863
25. H.C. Dietz, G.R. Cutting, R.E. Pyeritz, C.L. Maslen, L.Y. Sakai, G.M. Corson, E.G. Puffenberger, A. Hamosh, E.J. Nanthakumar, and S.M. Curristin Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene Nature 352 1991 337 339
26. P. Elliott, J.C. Chambers, W. Zhang, R. Clarke, J.C. Hopewell, J.F. Peden, J. Erdmann, P. Braund, J.C. Engert, and D. Bennett Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease JAMA 302 2009 37 48
27. J. Erdmann, A. Grosshennig, P.S. Braund, I.R. König, C. Hengstenberg, A.S. Hall, P. Linsel-Nitschke, S. Kathiresan, B. Wright, D.A. Trégouët Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group Myocardial Infarction Genetics Consortium Wellcome Trust Case Control Consortium Cardiogenics Consortium New susceptibility locus for coronary artery disease on chromosome 3q22.3 Nat. Genet. 41 2009 280 282
28. J. Ernst, P. Kheradpour, T.S. Mikkelsen, N. Shoresh, L.D. Ward, C.B. Epstein, X. Zhang, L. Wang, R. Issner, and M. Coyne Mapping and analysis of chromatin state dynamics in nine human cell types Nature 473 2011 43 49
29. L. Faivre, G. Collod-Beroud, B.L. Loeys, A. Child, C. Binquet, E. Gautier, B. Callewaert, E. Arbustini, K. Mayer, and M. Arslan-Kirchner Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study Am. J. Hum. Genet. 81 2007 454 466
30. C.K. Garcia, K. Wilund, M. Arca, G. Zuliani, R. Fellin, M. Maioli, S. Calandra, S. Bertolini, F. Cossu, and N. Grishin Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein Science 292 2001 1394 1398
31. V. Garg, I.S. Kathiriya, R. Barnes, M.K. Schluterman, I.N. King, C.A. Butler, C.R. Rothrock, R.S. Eapen, K. Hirayama-Yamada, and K. Joo GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 Nature 424 2003 443 447
32. V. Garg, A.N. Muth, J.F. Ransom, M.K. Schluterman, R. Barnes, I.N. King, P.D. Grossfeld, and D. Srivastava Mutations in NOTCH1 cause aortic valve disease Nature 437 2005 270 274
33. A.A. Geisterfer-Lowrance, S. Kass, G. Tanigawa, H.P. Vosberg, W. McKenna, C.E. Seidman, and J.G. Seidman A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation Cell 62 1990 999 1006
34. B.D. Gelb, and M. Tartaglia RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it J. Clin. Invest. 121 2011 844 847
35. D.S. Geller, J. Rodriguez-Soriano, A. Vallo Boado, S. Schifter, M. Bayer, S.S. Chang, and R.P. Lifton Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I Nat. Genet. 19 1998 279 281
36. D.S. Geller, A. Farhi, N. Pinkerton, M. Fradley, M. Moritz, A. Spitzer, G. Meinke, F.T. Tsai, P.B. Sigler, and R.P. Lifton Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy Science 289 2000 119 123
37. C. Gieger, A. Radhakrishnan, A. Cvejic, W. Tang, E. Porcu, G. Pistis, J. Serbanovic-Canic, U. Elling, A.H. Goodall, and Y. Labrune New gene functions in megakaryopoiesis and platelet formation Nature 480 2011 201 208
38. R. Gray, and K. Wheatley How to avoid bias when comparing bone marrow transplantation with chemotherapy Bone Marrow Transplant. 7 1991 9 12
39. D.F. Gudbjartsson, U.S. Bjornsdottir, E. Halapi, A. Helgadottir, P. Sulem, G.M. Jonsdottir, G. Thorleifsson, H. Helgadottir, V. Steinthorsdottir, and H. Stefansson Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction Nat. Genet. 41 2009 342 347
40. J.H. Hansson, C. Nelson-Williams, H. Suzuki, L. Schild, R. Shimkets, Y. Lu, C. Canessa, T. Iwasaki, B. Rossier, and R.P. Lifton Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome Nat. Genet. 11 1995 76 82
41. O. Harismendy, D. Notani, X. Song, N.G. Rahim, B. Tanasa, N. Heintzman, B. Ren, X.D. Fu, E.J. Topol, M.G. Rosenfeld, and K.A. Frazer 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response Nature 470 2011 264 268
42. A. Helgadottir, G. Thorleifsson, A. Manolescu, S. Gretarsdottir, T. Blondal, A. Jonasdottir, A. Jonasdottir, A. Sigurdsson, A. Baker, and A. Palsson A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493
43. L.A. Hindorff, P. Sethupathy, H.A. Junkins, E.M. Ramos, J.P. Mehta, F.S. Collins, and T.A. Manolio Potential etiologic and functional implications of genome-wide association loci for human diseases and traits Proc. Natl. Acad. Sci. USA 106 2009 9362 9367
44. H.H. Hobbs, E. Leitersdorf, C.C. Leffert, D.R. Cryer, M.S. Brown, and J.L. Goldstein Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors J. Clin. Invest. 84 1989 656 664
45. L.M. Holdt, and D. Teupser Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations Arterioscler. Thromb. Vasc. Biol. 32 2012 196 206
46. IBC 50K CAD Consortium Large-scale gene-centric analysis identifies novel variants for coronary artery disease PLoS Genet. 7 2011 e1002260
47. M. Ieda, J.D. Fu, P. Delgado-Olguin, V. Vedantham, Y. Hayashi, B.G. Bruneau, and D. Srivastava Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors Cell 142 2010 375 386
48. I. Itzhaki, L. Maizels, I. Huber, L. Zwi-Dantsis, O. Caspi, A. Winterstern, O. Feldman, A. Gepstein, G. Arbel, and H. Hammerman Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
49. J.A. Jarcho, W. McKenna, J.A. Pare, S.D. Solomon, R.F. Holcombe, S. Dickie, T. Levi, H. Donis-Keller, J.G. Seidman, and C.E. Seidman Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1 N. Engl. J. Med. 321 1989 1372 1378
50. W. Ji, J.N. Foo, B.J. O'Roak, H. Zhao, M.G. Larson, D.B. Simon, C. Newton-Cheh, M.W. State, D. Levy, and R.P. Lifton Rare independent mutations in renal salt handling genes contribute to blood pressure variation Nat. Genet. 40 2008 592 599
51. C.T. Johansen, J. Wang, M.B. Lanktree, H. Cao, A.D. McIntyre, M.R. Ban, R.A. Martins, B.A. Kennedy, R.G. Hassell, and M.E. Visser Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia Nat. Genet. 42 2010 684 687
52. P.R. Kamstrup, A. Tybjaerg-Hansen, R. Steffensen, and B.G. Nordestgaard Genetically elevated lipoprotein(a) and increased risk of myocardial infarction JAMA 301 2009 2331 2339
53. W.B. Kannel, T.R. Dawber, A. Kagan, N. Revotskie, and J. Stokes III Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham Study Ann. Intern. Med. 55 1961 33 50
54. M.B. Katan Apolipoprotein E isoforms, serum cholesterol, and cancer Lancet 1 1986 507 508
55. S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N.P. Burtt, M.J. Rieder, G.M. Cooper, C. Roos, B.F. Voight, and A.S. Havulinna Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat. Genet. 40 2008 189 197
56. S. Kathiresan, B.F. Voight, S. Purcell, K. Musunuru, D. Ardissino, P.M. Mannucci, S. Anand, J.C. Engert, N.J. Samani, H. Schunkert Myocardial Infarction Genetics Consortium Wellcome Trust Case Control Consortium Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Nat. Genet. 41 2009 334 341
57. S. Kathiresan, C.J. Willer, G.M. Peloso, S. Demissie, K. Musunuru, E.E. Schadt, L. Kaplan, D. Bennett, Y. Li, and T. Tanaka Common variants at 30 loci contribute to polygenic dyslipidemia Nat. Genet. 41 2009 56 65
58. A. Kimura, H. Harada, J.E. Park, H. Nishi, M. Satoh, M. Takahashi, S. Hiroi, T. Sasaoka, N. Ohbuchi, and T. Nakamura Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy Nat. Genet. 16 1997 379 382
59. G.V. Kryukov, L.A. Pennacchio, and S.R. Sunyaev Most rare missense alleles are deleterious in humans: implications for complex disease and association studies Am. J. Hum. Genet. 80 2007 727 739
60. G.V. Kryukov, A. Shpunt, J.A. Stamatoyannopoulos, and S.R. Sunyaev Power of deep, all-exon resequencing for discovery of human trait genes Proc. Natl. Acad. Sci. USA 106 2009 3871 3876
61. M.A. Lehrman, W.J. Schneider, T.C. Südhof, M.S. Brown, J.L. Goldstein, and D.W. Russell Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains Science 227 1985 140 146
62. S.A. Lemaire, M.L. McDonald, D.C. Guo, L. Russell, C.C. Miller III, R.J. Johnson, M.R. Bekheirnia, L.M. Franco, M. Nguyen, and R.E. Pyeritz Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1 Nat. Genet. 43 2011 996 1000
63. B. Li, and S.M. Leal Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data Am. J. Hum. Genet. 83 2008 311 321
64. R.P. Lifton, R.G. Dluhy, M. Powers, G.M. Rich, S. Cook, S. Ulick, and J.M. Lalouel A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension Nature 355 1992 262 265
65. R.P. Lifton, R.G. Dluhy, M. Powers, G.M. Rich, M. Gutkin, F. Fallo, J.R. Gill Jr., L. Feld, A. Ganguly, and J.C. Laidlaw Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase Nat. Genet. 2 1992 66 74
66. R.P. Lifton, A.G. Gharavi, and D.S. Geller Molecular mechanisms of human hypertension Cell 104 2001 545 556
67. E.A. Lindsay, F. Vitelli, H. Su, M. Morishima, T. Huynh, T. Pramparo, V. Jurecic, G. Ogunrinu, H.F. Sutherland, and P.J. Scambler Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice Nature 410 2001 97 101
68. M.E. Lindsay, and H.C. Dietz Lessons on the pathogenesis of aneurysm from heritable conditions Nature 473 2011 308 316
69. D.M. Lloyd-Jones, B.H. Nam, R.B. D'Agostino Sr., D. Levy, J.M. Murabito, T.J. Wang, P.W. Wilson, and C.J. O'Donnell Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring JAMA 291 2004 2204 2211
70. D.G. MacArthur, S. Balasubramanian, A. Frankish, N. Huang, J. Morris, K. Walter, L. Jostins, L. Habegger, J.K. Pickrell, and S.B. Montgomery A systematic survey of loss-of-function variants in human protein-coding genes Science 335 2012 823 828
71. B.E. Madsen, and S.R. Browning A groupwise association test for rare mutations using a weighted sum statistic PLoS Genet. 5 2009 e1000384
72. A. Mani, J. Radhakrishnan, H. Wang, M.A. Mani, C. Nelson-Williams, K.S. Carew, S. Mane, H. Najmabadi, D. Wu, and R.P. Lifton LRP6 mutation in a family with early coronary disease and metabolic risk factors Science 315 2007 1278 1282
73. T.A. Manolio, F.S. Collins, N.J. Cox, D.B. Goldstein, L.A. Hindorff, D.J. Hunter, M.I. McCarthy, E.M. Ramos, L.R. Cardon, and A. Chakravarti Finding the missing heritability of complex diseases Nature 461 2009 747 753
74. J. McClellan, and M.C. King Genetic heterogeneity in human disease Cell 141 2010 210 217
75. W.P. McNair, L. Ku, M.R. Taylor, P.R. Fain, D. Dao, E. Wolfel, L. Mestroni Familial Cardiomyopathy Registry Research Group SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia Circulation 110 2004 2163 2167
76. R. McPherson, A. Pertsemlidis, N. Kavaslar, A. Stewart, R. Roberts, D.R. Cox, D.A. Hinds, L.A. Pennacchio, A. Tybjaerg-Hansen, and A.R. Folsom A common allele on chromosome 9 associated with coronary heart disease Science 316 2007 1488 1491
77. S. Menzel, C. Garner, I. Gut, F. Matsuda, M. Yamaguchi, S. Heath, M. Foglio, D. Zelenika, A. Boland, and H. Rooks A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 Nat. Genet. 39 2007 1197 1199
78. A. Moretti, M. Bellin, A. Welling, C.B. Jung, J.T. Lam, L. Bott-Flügel, T. Dorn, A. Goedel, C. Höhnke, and F. Hofmann Patient-specific induced pluripotent stem-cell models for long-QT syndrome N. Engl. J. Med. 363 2010 1397 1409
79. T. Mune, F.M. Rogerson, H. Nikkilä, A.K. Agarwal, and P.C. White Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase Nat. Genet. 10 1995 394 399
80. K. Musunuru, and S. Kathiresan Genetics of coronary artery disease Annu. Rev. Genomics Hum. Genet. 11 2010 91 108
81. K. Musunuru, J.P. Pirruccello, R. Do, G.M. Peloso, C. Guiducci, C. Sougnez, K.V. Garimella, S. Fisher, J. Abreu, and A.J. Barry Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia N. Engl. J. Med. 363 2010 2220 2227
82. K. Musunuru, A. Strong, M. Frank-Kamenetsky, N.E. Lee, T. Ahfeldt, K.V. Sachs, X. Li, H. Li, N. Kuperwasser, and V.M. Ruda From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus Nature 466 2010 714 719
83. B.M. Neale, M.A. Rivas, B.F. Voight, D. Altshuler, B. Devlin, M. Orho-Melander, S. Kathiresan, S.M. Purcell, K. Roeder, and M.J. Daly Testing for an unusual distribution of rare variants PLoS Genet. 7 2011 e1001322
84. C. Newton-Cheh, M. Eijgelsheim, K.M. Rice, P.I. de Bakker, X. Yin, K. Estrada, J.C. Bis, K. Marciante, F. Rivadeneira, and P.A. Noseworthy Common variants at ten loci influence QT interval duration in the QTGEN Study Nat. Genet. 41 2009 399 406
85. S.B. Ng, K.J. Buckingham, C. Lee, A.W. Bigham, H.K. Tabor, K.M. Dent, C.D. Huff, P.T. Shannon, E.W. Jabs, and D.A. Nickerson Exome sequencing identifies the cause of a mendelian disorder Nat. Genet. 42 2010 30 35
86. N. Norton, D. Li, M.J. Rieder, J.D. Siegfried, E. Rampersaud, S. Züchner, S. Mangos, J. Gonzalez-Quintana, L. Wang, and S. McGee Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy Am. J. Hum. Genet. 88 2011 273 282
87. C.J. O'Donnell, and E.G. Nabel Genomics of cardiovascular disease N. Engl. J. Med. 365 2011 2098 2109
88. T.M. Olson, T.P. Doan, N.Y. Kishimoto, F.G. Whitby, M.J. Ackerman, and L. Fananapazir Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy J. Mol. Cell. Cardiol. 32 2000 1687 1694
89. K. Poetter, H. Jiang, S. Hassanzadeh, S.R. Master, A. Chang, M.C. Dalakas, I. Rayment, J.R. Sellers, L. Fananapazir, and N.D. Epstein Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle Nat. Genet. 13 1996 63 69
90. T.I. Pollin, C.M. Damcott, H. Shen, S.H. Ott, J. Shelton, R.B. Horenstein, W. Post, J.C. McLenithan, L.F. Bielak, and P.A. Peyser A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection Science 322 2008 1702 1705
91. A.L. Price, G.V. Kryukov, P.I. de Bakker, S.M. Purcell, J. Staples, L.J. Wei, and S.R. Sunyaev Pooled association tests for rare variants in exon-resequencing studies Am. J. Hum. Genet. 86 2010 832 838
92. S. Raychaudhuri Mapping rare and common causal alleles for complex human diseases Cell 147 2011 57 69
93. M.P. Reilly, M. Li, J. He, J.F. Ferguson, I.M. Stylianou, N.N. Mehta, M.S. Burnett, J.M. Devaney, C.W. Knouff, J.R. Thompson Myocardial Infarction Genetics Consortium Wellcome Trust Case Control Consortium Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies Lancet 377 2011 383 392
94. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox American Heart Association Statistics Committee and Stroke Statistics Subcommittee Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 188 197
95. S. Romeo, W. Yin, J. Kozlitina, L.A. Pennacchio, E. Boerwinkle, H.H. Hobbs, and J.C. Cohen Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans J. Clin. Invest. 119 2009 70 79
96. N.J. Samani, J. Erdmann, A.S. Hall, C. Hengstenberg, M. Mangino, B. Mayer, R.J. Dixon, T. Meitinger, P. Braund, H.E. Wichmann WTCCC and the Cardiogenics Consortium Genomewide association analysis of coronary artery disease N. Engl. J. Med. 357 2007 443 453
97. V.G. Sankaran, T.F. Menne, J. Xu, T.E. Akie, G. Lettre, B. Van Handel, H.K. Mikkola, J.N. Hirschhorn, A.B. Cantor, and S.H. Orkin Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A Science 322 2008 1839 1842
98. V.G. Sankaran, J. Xu, T. Ragoczy, G.C. Ippolito, C.R. Walkley, S.D. Maika, Y. Fujiwara, M. Ito, M. Groudine, and M.A. Bender Developmental and species-divergent globin switching are driven by BCL11A Nature 460 2009 1093 1097
99. E.E. Schadt, C. Molony, E. Chudin, K. Hao, X. Yang, P.Y. Lum, A. Kasarskis, B. Zhang, S. Wang, and C. Suver Mapping the genetic architecture of gene expression in human liver PLoS Biol. 6 2008 e107
100. J.J. Schott, D.W. Benson, C.T. Basson, W. Pease, G.M. Silberbach, J.P. Moak, B.J. Maron, C.E. Seidman, and J.G. Seidman Congenital heart disease caused by mutations in the transcription factor NKX2-5 Science 281 1998 108 111
101. J.J. Schott, C. Alshinawi, F. Kyndt, V. Probst, T.M. Hoorntje, M. Hulsbeek, A.A. Wilde, D. Escande, M.M. Mannens, and H. Le Marec Cardiac conduction defects associate with mutations in SCN5A Nat. Genet. 23 1999 20 21
102. H. Schunkert, I.R. König, S. Kathiresan, M.P. Reilly, T.L. Assimes, H. Holm, M. Preuss, A.F. Stewart, M. Barbalic, C. Gieger Cardiogenics CARDIoGRAM Consortium Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat. Genet. 43 2011 333 338
103. J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
104. J. Shea, V. Agarwala, A.A. Philippakis, J. Maguire, E. Banks, M. Depristo, B. Thomson, C. Guiducci, R.C. Onofrio, S. Kathiresan Myocardial Infarction Genetics Consortium Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction Nat. Genet. 43 2011 801 805
105. R.A. Shimkets, D.G. Warnock, C.M. Bositis, C. Nelson-Williams, J.H. Hansson, M. Schambelan, J.R. Gill Jr., S. Ulick, R.V. Milora, and J.W. Findling Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel Cell 79 1994 407 414
106. D.B. Simon, F.E. Karet, J.M. Hamdan, A. DiPietro, S.A. Sanjad, and R.P. Lifton Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2 Nat. Genet. 13 1996 183 188
107. D.B. Simon, F.E. Karet, J. Rodriguez-Soriano, J.H. Hamdan, A. DiPietro, H. Trachtman, S.A. Sanjad, and R.P. Lifton Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK Nat. Genet. 14 1996 152 156
108. D.B. Simon, C. Nelson-Williams, M.J. Bia, D. Ellison, F.E. Karet, A.M. Molina, I. Vaara, F. Iwata, H.M. Cushner, and M. Koolen Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter Nat. Genet. 12 1996 24 30
109. D.B. Simon, R.S. Bindra, T.A. Mansfield, C. Nelson-Williams, E. Mendonca, R. Stone, S. Schurman, A. Nayir, H. Alpay, and A. Bakkaloglu Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III Nat. Genet. 17 1997 171 178
110. L.F. Soria, E.H. Ludwig, H.R. Clarke, G.L. Vega, S.M. Grundy, and B.J. McCarthy Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 Proc. Natl. Acad. Sci. USA 86 1989 587 591
111. C. St Hilaire, S.G. Ziegler, T.C. Markello, A. Brusco, C. Groden, F. Gill, H. Carlson-Donohoe, R.J. Lederman, M.Y. Chen, and D. Yang NT5E mutations and arterial calcifications N. Engl. J. Med. 364 2011 432 442
112. P.D. Stenson, M. Mort, E.V. Ball, K. Howells, A.D. Phillips, N.S. Thomas, and D.N. Cooper The Human Gene Mutation Database: 2008 update Genome. Med. 1 2009 13
113. S. Sunyaev, V. Ramensky, I. Koch, W. Lathe III, A.S. Kondrashov, and P. Bork Prediction of deleterious human alleles Hum. Mol. Genet. 10 2001 591 597
114. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
115. M. Tartaglia, E.L. Mehler, R. Goldberg, G. Zampino, H.G. Brunner, H. Kremer, I. van der Burgt, A.H. Crosby, A. Ion, and S. Jeffery Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome Nat. Genet. 29 2001 465 468
116. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, M. Koseki, J.P. Pirruccello, S. Ripatti, D.I. Chasman, and C.J. Willer Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
117. D. Teupser, R. Baber, U. Ceglarek, M. Scholz, T. Illig, C. Gieger, L.M. Holdt, A. Leichtle, K.H. Greiser, and D. Huster Genetic regulation of serum phytosterol levels and risk of coronary artery disease Circ. Cardiovasc. Genet. 3 2010 331 339
118. L. Thierfelder, H. Watkins, C. MacRae, R. Lamas, W. McKenna, H.P. Vosberg, J.G. Seidman, and C.E. Seidman Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere Cell 77 1994 701 712
119. A. Varbo, M. Benn, A. Tybjærg-Hansen, P. Grande, and B.G. Nordestgaard TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population Arterioscler. Thromb. Vasc. Biol. 31 2011 451 457
120. A. Visel, Y. Zhu, D. May, V. Afzal, E. Gong, C. Attanasio, M.J. Blow, J.C. Cohen, E.M. Rubin, and L.A. Pennacchio Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice Nature 464 2010 409 412
121. Q. Wang, J. Shen, I. Splawski, D. Atkinson, Z. Li, J.L. Robinson, A.J. Moss, J.A. Towbin, and M.T. Keating SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome Cell 80 1995 805 811
122. F. Wang, C.Q. Xu, Q. He, J.P. Cai, X.C. Li, D. Wang, X. Xiong, Y.H. Liao, Q.T. Zeng, and Y.Z. Yang Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population Nat. Genet. 43 2011 345 349
123. H. Watkins, D. Conner, L. Thierfelder, J.A. Jarcho, C. MacRae, W.J. McKenna, B.J. Maron, J.G. Seidman, and C.E. Seidman Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy Nat. Genet. 11 1995 434 437
124. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678
125. F. Wensley, P. Gao, S. Burgess, S. Kaptoge, E. Di Angelantonio, T. Shah, J.C. Engert, R. Clarke, G. Davey-Smith, B.G. Nordestgaard C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data BMJ 342 2011 d548
126. P.S. Wild, T. Zeller, A. Schillert, S. Szymczak, C.R. Sinning, A. Deiseroth, R.B. Schnabel, E. Lubos, T. Keller, and M.S. Eleftheriadis A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease Circ. Cardiovasc. Genet. 4 2011 403 412
127. C.J. Willer, S. Sanna, A.U. Jackson, A. Scuteri, L.L. Bonnycastle, R. Clarke, S.C. Heath, N.J. Timpson, S.S. Najjar, and H.M. Stringham Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat. Genet. 40 2008 161 169
128. F.H. Wilson, S. Disse-Nicodme, K.A. Choate, K. Ishikawa, C. Nelson-Williams, I. Desitter, M. Gunel, D.V. Milford, G.W. Lipkin, and J.M. Achard Human hypertension caused by mutations in WNK kinases Science 293 2001 1107 1112
129. J. Xu, V.G. Sankaran, M. Ni, T.F. Menne, R.V. Puram, W. Kim, and S.H. Orkin Transcriptional silencing of gamma-globin by BCL11A involves long-range interactions and cooperation with SOX6 Genes Dev. 24 2010 783 798
130. J. Xu, C. Peng, V.G. Sankaran, Z. Shao, E.B. Esrick, B.G. Chong, G.C. Ippolito, Y. Fujiwara, B.L. Ebert, P.W. Tucker, and S.H. Orkin Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing Science 334 2011 993 996
131. K. Yasuno, K. Bilguvar, P. Bijlenga, S.K. Low, B. Krischek, G. Auburger, M. Simon, D. Krex, Z. Arlier, and N. Nayak Genome-wide association study of intracranial aneurysm identifies three new risk loci Nat. Genet. 42 2010 420 425
132. M. Yazawa, B. Hsueh, X. Jia, A.M. Pasca, J.A. Bernstein, J. Hallmayer, and R.E. Dolmetsch Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome Nature 471 2011 230 234
133. K. Yusa, S.T. Rashid, H. Strick-Marchand, I. Varela, P.Q. Liu, D.E. Paschon, E. Miranda, A. Ordóñez, N.R. Hannan, and F.J. Rouhani Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells Nature 478 2011 391 394
134. J. Zacho, A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N. Engl. J. Med. 359 2008 1897 1908